Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells

Version 1 : Received: 19 April 2024 / Approved: 19 April 2024 / Online: 19 April 2024 (16:08:57 CEST)

How to cite: Maddaloni, M.; Farra, R.; Dapas, B.; Felluga, F.; Benedetti, F.; Berti, F.; Drioli, S.; Vidali, M.; Cemazar, M.; Kamensek, U.; Brancolini, C.; Murano, E.; Maremonti, F.; Grassi, M.; Biasin, A.; Rizzolio, F.; Cavarzerani, E.; Scaggiante, B.; Bulla, R.; Balduit, A.; Ricci, G.; Zito, G.; Romano, F.; Bonin, S.; Azzalini, E.; Baj, G.; Tierno, D.; Grassi, G. In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells. Preprints 2024, 2024041360. https://doi.org/10.20944/preprints202404.1360.v1 Maddaloni, M.; Farra, R.; Dapas, B.; Felluga, F.; Benedetti, F.; Berti, F.; Drioli, S.; Vidali, M.; Cemazar, M.; Kamensek, U.; Brancolini, C.; Murano, E.; Maremonti, F.; Grassi, M.; Biasin, A.; Rizzolio, F.; Cavarzerani, E.; Scaggiante, B.; Bulla, R.; Balduit, A.; Ricci, G.; Zito, G.; Romano, F.; Bonin, S.; Azzalini, E.; Baj, G.; Tierno, D.; Grassi, G. In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells. Preprints 2024, 2024041360. https://doi.org/10.20944/preprints202404.1360.v1

Abstract

Background: The identification of novel therapeutic strategies for Ovarian cancer (OC), the most lethal gynecological neoplasm, is of utmost urgency. Here, we have tested the effectiveness of the compound 2c (4-Hydroxy-2,6-bis(4-nitrobenzylidene)cyclohexanone 2). 2c interferes with cyste-ine-dependent deubiquitinating enzymes (DUBs), thus affecting the ubiquitin-proteasome de-pendent degradation of proteins. Methods: 2c phenotypic/molecular effects were studied in two OC cell lines, primary tumor cells cultured in 2D/3D and in a mouse xenograft model. We also propose an in-silico model of 2c interaction with DUBs. Finally, we tested the effect of 2c conju-gated to several linkers to generate 2c-derivatives usable for improved drug delivery. Results: 2c effectively impairs OC cell line and primary tumor cell viability in both 2D and 3D conditions. The effectiveness is confirmed in a xenograft mouse model of OC. We show that 2c impairs pro-teasome activity and triggers apoptosis most likely by interacting with DUBs; we propose a mechanism for the interaction with a model DUB via an in-silico evaluation of the en-zyme-inhibitor complex. 2c also reduces cell growth by down-regulating the level of the transcrip-tion factor E2F1. Finally, 2c activity is often retained after the conjugation with linkers. Conclu-sion: Our data strongly support the potential therapeutic value of 2c/derivatives in OC.

Keywords

ovarian cancer; 2C; apoptosis; E2F1, in silico docking.

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.